January Therapeutics is Drug Discovery in United States that focus on Developer novel therapeutics business. Founded in 2016. They cover business area such as developer novel therapeutic, anti-cancer therapy, cancer therapeutic, albumin nanoparticle formulation, initial application, advanced pancreatic, lung and ovarian cancer, physician, efficient therapy, sarcoma.
2016
( 10 years old in 2026 )
Developer Novel Therapeutics
-
11575 Sorrento Valley Road
Suite 212
San Diego, CA 92121
United States
Private
developer novel therapeuticanti-cancer therapycancer therapeuticalbumin nanoparticle formulationinitial applicationadvanced pancreatic, lung and ovarian cancerphysicianefficient therapysarcoma
* We use standard office opening hours in near January Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
January Therapeutics is Drug Discovery business from United States that founded in 2016 (10 years old in 2026), January Therapeutics business is focusing on Developer Novel Therapeutics.
January Therapeutics headquarter office and corporate office address is located in 11575 Sorrento Valley Road Suite 212 San Diego, CA 92121 United States.
January Therapeutics was founded in United States.
In 2026, January Therapeutics is currently focus on Developer novel therapeutics sector.
Above is snippet of Google Trends for "Developer novel therapeutics" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with January Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
